Hear the Latest Hemispherx News Directly from Tom Equels at NobleConXV

Our CEO, Tom Equels, recently spoke about Hemispherx’s work with four major cancer research centers, including a discussion of the ongoing Phase 1 and Phase 2 immuno-oncology clinical trials being conducted in the U.S. His remarks came at NobleConXV, Noble Capital Markets’ Fifteenth Annual Investor Conference, held in Fort Lauderdale, Fla.

Watch a high-definition of his presentation here.

Hemispherx News 05

Ready to talk?